| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 13, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 19,500 | $7.70 | $150,052.50 | -6.8% | |
| May 6, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 16,750 | $7.54 | $126,325.00 | -5.9% | |
| Apr 4, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 7,500 | $8.81 | $66,075.00 | -5.4% | |
| Mar 12, 2019 | Aselage Steve80 | Director | Buy | 2,000 | $8.30 | $16,600.00 | New | |
| Jan 28, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 5,000 | $9.85 | $49,250.00 | -3.7% | |
| Jan 28, 2019 | Powell Lynne | Senior VP - CCO | Sale+OE | 12,000 | $9.75 | $116,940.00 | -100% | |
| Jan 18, 2019 | Powell Lynne | Senior VP - CCO | Sale+OE | 2,000 | $9.40 | $18,800.00 | -100% | |
| Jan 16, 2019 | Powell Lynne | Senior VP - CCO | Sale+OE | 3,046 | $9.27 | $28,236.42 | -100% | |
| Jan 14, 2019 | Powell Lynne | Senior VP - CCO | Sale+OE | 954 | $9.20 | $8,776.80 | -100% | |
| Dec 18, 2018 | Sheridan William P67 | Senior VP - CMO | Sell | 20,488 | $7.58 | $155,299.04 | -88.3% |